Tomkiel Melissa M. 4

What Happened

• Melissa M. Tomkiel, Co-CEO, General Counsel and Director of Strata Critical Medical, received 630,264 shares on 2026-04-23 upon vesting of performance-based restricted stock units (PSUs). The grant is reported at $0 acquisition price (award).
• On 2026-04-24, 321,750 of those shares were withheld by the company to satisfy tax withholding obligations at an implied value of $4.92 per share, totaling $1,583,010. Net shares delivered to Tomkiel after withholding: 308,514.
• This sequence is an award/vesting plus issuer tax withholding (not an open-market sale by the insider).

Key Details

• Transaction dates/prices: 4/23/2026 — Award of 630,264 shares at $0.00 (code A); 4/24/2026 — 321,750 shares withheld at $4.92/share (code F), proceeds/withholding = $1,583,010.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Footnotes: F1 — shares were issued upon Compensation Committee certification that performance criteria for PSUs (granted 3/20/2025) were met. F2 — shares were withheld by the issuer to satisfy tax withholding.
• Filing timeliness: Form 4 filed 2026-04-27; filing covers 4/23 and 4/24 transactions and is timely (not marked late).

Context

• PSUs are performance-based awards; the award reflects compensation vesting, not a market purchase. The withholding is a routine, issuer-handled tax payment (common in equity compensation).
• For investors, awards indicate executive compensation realization but do not, by themselves, indicate buying or selling intent.